{
    "nctId": "NCT01521000",
    "briefTitle": "The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient",
    "officialTitle": "The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "To determine whether early intervention in patients with pre-clinical lymphedema can halt the progression of lymphedema.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* are female\n* have operable, early stage breast cancer stage 0 - IIIA\n* undergo axillary evaluation with either sentinel lymph node biopsy or axillary lymph node dissection\n* are aged \\> 18 years of age at the date of enrollment\n* are willing to sign an informed consent form\n\nExclusion Criteria:\n\n* are male\n* have had a bilateral axillary surgery\n* do not undergo axillary evaluation\n* are a minor\n* cannot consider the issues involved in making an informed and autonomous decision.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}